Crohn's disease

M Dolinger, J Torres, S Vermeire - The Lancet, 2024‏ - thelancet.com
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract that might lead
to progressive bowel damage and disability. The exact cause of Crohn's disease is …

Calprotectin: from biomarker to biological function

A Jukic, L Bakiri, EF Wagner, H Tilg, TE Adolph - Gut, 2021‏ - gut.bmj.com
The incidence of inflammatory bowel diseases (IBD) emerged with Westernisation of dietary
habits worldwide. Crohn's disease and ulcerative colitis are chronic debilitating conditions …

ECCO guidelines on therapeutics in Crohn's disease: medical treatment

H Gordon, S Minozzi, U Kopylov… - Journal of Crohn's …, 2024‏ - academic.oup.com
Crohn's disease [CD] is a chronic inflammatory bowel disease [IBD] that can result in
progressive bowel damage and disability. 1 CD can affect individuals of any age, from …

[HTML][HTML] Follow-up study to evaluate the long-term safety and efficacy of darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn's …

D Garcia-Olmo, I Gilaberte, M Binek… - Diseases of the Colon …, 2022‏ - journals.lww.com
BACKGROUND: Darvadstrocel is an expanded allogeneic adipose-derived mesenchymal
stem cell therapy for the treatment of complex perianal fistulas in patients with Crohn's …

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting

TL Parigi, F D'Amico, MT Abreu, A Dignass… - The Lancet …, 2023‏ - thelancet.com
Many patients with inflammatory bowel disease (IBD) have persistent symptoms and
disease activity despite the best available medical or surgical treatments. These patients are …

Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn “der Deutschen Gesellschaft für Gastroenterologie, Verdauungs-und Stoffwechselkrankheiten …

A Sturm, R Atreya, D Bettenworth… - Zeitschrift für …, 2022‏ - thieme-connect.com
Im Jahr 2019 wurden etwa 25 500 Patient* innen mit M. Crohn im Krankenhaus stationär
behandelt [1]. Meistens tritt die Erkrankung in der Adoleszenz und im jungen …

May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients' questions? An evidence-controlled analysis

AG Gravina, R Pellegrino, M Cipullo… - World Journal of …, 2024‏ - pmc.ncbi.nlm.nih.gov
Artificial intelligence is increasingly entering everyday healthcare. Large language model
(LLM) systems such as Chat Generative Pre-trained Transformer (ChatGPT) have become …

Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review

Y Liu, J Huang, S Li, Z Li, C Chen, G Qu, K Chen… - Biomaterials …, 2024‏ - pubs.rsc.org
Inflammatory bowel disease (IBD) is a chronic disorder that affects millions of individuals
worldwide. However, current drug therapies for IBD are plagued by significant side effects …

Management of inflammatory bowel diseases in older adults

S Singh, BS Boland, T Jess, AA Moore - The lancet Gastroenterology …, 2023‏ - thelancet.com
The burden of inflammatory bowel disease (IBD) in older adults (ie, aged over 60 years old)
is increasing due to a combination of an ageing population with compounding prevalence of …

[HTML][HTML] European guideline on obesity care in patients with gastrointestinal and liver diseases–Joint ESPEN/UEG guideline

SC Bischoff, R Barazzoni, L Busetto… - Clinical Nutrition, 2022‏ - Elsevier
Background Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel
disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux …